Pharmafile Logo

OPEN Health Appoints Richard Jones as President for Evidence & Access

June 29, 2023 |  

OPEN Health is pleased to announce the appointment of Richard Jones as President for Evidence & Access.

June 29, 2023, London, UK – OPEN Health is pleased to announce the appointment of Richard Jones as President of the Evidence & Access (E&A) practice. In this role, he will lead OPEN Health’s HEOR and market access teams while showcasing and enhancing scientific leadership, expanding client partnerships, and developing talent to fuel the growth of the business.

Richard has been with OPEN Health for 10 years, most recently in the role of leading the OPEN Health patient engagement team, and he has 25+ years’ experience conducting patient-centered research for clients in the biopharmaceutical sector. A frequently invited speaker and panelist on patient engagement topics at international conferences and scientific venues, Richard has a passion for crystallizing issues around patient engagement and developing innovative solutions.

Commenting on his appointment, Richard said, “I have been fortunate enough to work at OPEN Health for a number of years, and my firm belief is that our strength lies in our people, our scientific leadership, and our innovative, collaborative mindset for solving some of our clients’ most challenging problems.”

Rob Barker, Group CEO, added, “Appointing Richard marks the next step in our exciting journey. He brings with him a strong people and patient-focused mindset, and his expertise in leading global teams will help guide our Evidence & Access practice to achieve its short and long-term goals in support of the overall OPEN Health Group strategy.”

Contact us for more information.

This content was provided by OPEN Health

Company Details

 Latest Content from  OPEN Health 

OPEN X Health launches to provide data-driven creativity to the pharmaceutical industry

OPEN X Health launches to provide data-driven creativity to the pharmaceutical industry

OPEN Health Appoints Steven Duryee as Chief Operating and Transformation Officer

OPEN Health Appoints Steven Duryee as Chief Operating and Transformation Officer

Unlock possibilities: A Medical Affairs strategy fit for the future

Explore the key areas to include in a Medical Affairs strategy and plan that is fit for the future in our latest whitepaper.

OPEN Health and Nested Knowledge announce strategic research collaboration to leverage AI technologies for evidence synthesis

OPEN Health and Nested Knowledge announce strategic research collaboration to leverage AI technologies for evidence synthesis

OPEN Health unites patient engagement experts to transform the patient experience

OPEN Health, a preeminent global provider of consulting, HEOR and market access, patient engagement, and scientific and creative communications services, is bringing together experts in strategic patient innovation and engagement,...

The right measurement frameworks matter for demonstrating treatment efficacy in clinical trials for Alzheimer’s Disease

The right measurement frameworks matter for demonstrating treatment efficacy in clinical trials for Alzheimer’s Disease

OPEN Health Presenting Innovative Research on Capitalizing Data for Patient Access at ISPOR Europe

OPEN Health Presenting Innovative Research on Capitalizing Data for Patient Access at ISPOR Europe

Dom Marchant, Chief Creative Officer, joins the executive leadership team at OPEN Health with a new vision to drive the creative communications practice

Dom Marchant, Chief Creative Officer, joins the executive leadership team at OPEN Health with a new vision to drive the creative communications practice

Embracing the Patient Voice Within Publications

This whitepaper will explore multidisciplinary perspectives on how we can better engage patient communities in publications to optimize the value of their contributions, while navigating any uncertainties and reluctance from...

Navigating the nocebo effect through patient engagement is the key to setting patients up for success

If you're interested in delving deeper into this topic and understanding how patient engagement can effectively navigate the nocebo effect, we invite you to explore our latest whitepaper.